LATS1 and cancer: Furthermore, loss of LATS1/2 or overexpression of YAP is sufficient to reprogram cancer stem cells to attenuate Wnt signaling, thereby suppressing tumor growth in organoids, patient-derived xenografts, and mouse models of primary and metastatic colorectal cancer (CRC) [44].